Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
21 results
D3.66 - National Survey on Perioperative Hypersensitivity Reactions: Clinical and Epidemiological Insights from Spanish Hospitals
D3.67 - Desensitization to Pertuzumab in a Patient with a Mixed Hipersensitivity Reaction
D3.69 - Tissue-Specific Allergen Distribution in Blue Swimmer Crab (Portunus pelagicus): Implications for Shellfish Allergy Diagnostics
D3.70 - Multiple Food Protein-Induced Enteropathy Syndrome: The Role of Skin Patch Testing in Guiding Effective Decision-Making
D3.71 - Anaphylaxis Induced by Macrogol: A Case Report
D3.72 - Utility of Basophil Activation Testing in Drug and Peanut Allergy: Concordance with Clinical Outcomes
D3.73 - Review of skin testing for delay hypersensitivity drug reactions, possible covariates involved in the results
D3.77 - Hypersensitivity Reactions to Iodinated Contrast Media: A Single-Center Experience
D3.78 - A rare case of scombroid syndrome with hypotension and biphasic course
D3.79 - Occupational Asthma due to Inhaled Mare's Milk Exposure and Anaphylaxis Associated with Plantago ovata
D3.82 - Could Lipid Transfer Protein Induced Anaphylaxis Be a Surprising Outcome of Sleeve Gastrectomy?
D3.265 - Biphasic anaphylaxis secondary to polyethylene glycol in a pediatric patient: a case report
D3.268 - Chronic Allergen Exposure Induces Accumulation of IgE Plasma Cells in the Lung, Leading to Local IgE Antibody Production
D3.269 - Drug-Induced Anaphylaxis in Children: A Comparative Analysis of Inpatient vs. Outpatient Settings
D3.270 - A novel workflow for cell metabolomics: impact of anaphylaxis in a human endothelial system
D3.272 - Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients
D3.273 - Assessing Anaphylaxis in COVID-19 vaccines: Application of amended Brighton Collaboration Criteria
D3.274 - Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria
D3.275 - Anaphylaxis caused by polyhexanide
D3.276 - Acalabrutinib as premedication in platinum agents desensitization protocols: a case series supporting its role in enhancing tolerance with a repeatible efficacity
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download